KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Other Non-Current Liabilities (2016 - 2025)

Boston Scientific (BSX) has disclosed Other Non-Current Liabilities for 17 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 28.61% to $2.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 billion through Dec 2025, up 28.61% year-over-year, with the annual reading at $2.4 billion for FY2025, 28.61% up from the prior year.
  • Other Non-Current Liabilities hit $2.4 billion in Q4 2025 for Boston Scientific, up from $2.4 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.4 billion in Q4 2025 to a low of $1.8 billion in Q2 2024.
  • Historically, Other Non-Current Liabilities has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2022.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 364.71% in 2021 and later decreased 16.55% in 2022.
  • Year by year, Other Non-Current Liabilities stood at $2.2 billion in 2021, then fell by 8.33% to $2.0 billion in 2022, then decreased by 3.34% to $2.0 billion in 2023, then decreased by 4.93% to $1.9 billion in 2024, then rose by 28.61% to $2.4 billion in 2025.
  • Business Quant data shows Other Non-Current Liabilities for BSX at $2.4 billion in Q4 2025, $2.4 billion in Q3 2025, and $2.4 billion in Q2 2025.